

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 8.69147390 |
| 2 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 7.80295762 |
| 3 | * cellular response to type I interferon (GO:0071357) | 7.78310340 |
| 4 | * type I interferon signaling pathway (GO:0060337) | 7.78310340 |
| 5 | * response to type I interferon (GO:0034340) | 7.66112460 |
| 6 | regulation of activation of Janus kinase activity (GO:0010533) | 7.18266328 |
| 7 | cellular response to interferon-alpha (GO:0035457) | 7.01085382 |
| 8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.61578124 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.24664203 |
| 10 | positive regulation of heat generation (GO:0031652) | 6.13591002 |
| 11 | regulation of fever generation (GO:0031620) | 6.10312718 |
| 12 | response to peptidoglycan (GO:0032494) | 6.05215965 |
| 13 | positive regulation of T-helper cell differentiation (GO:0045624) | 5.72756913 |
| 14 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.67035587 |
| 15 | response to interferon-alpha (GO:0035455) | 5.42475658 |
| 16 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.30352393 |
| 17 | * positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 5.26225933 |
| 18 | * regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 5.26225933 |
| 19 | regulation of memory T cell differentiation (GO:0043380) | 5.18812004 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 5.18732254 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.97174256 |
| 22 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.90260529 |
| 23 | * regulation of MHC class I biosynthetic process (GO:0045343) | 4.88861090 |
| 24 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 4.86649101 |
| 25 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.82212099 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 4.76130096 |
| 27 | regulation of heat generation (GO:0031650) | 4.67843458 |
| 28 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.62519176 |
| 29 | regulation of T-helper cell differentiation (GO:0045622) | 4.56198826 |
| 30 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.55439373 |
| 31 | negative regulation by host of viral transcription (GO:0043922) | 4.54786412 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.50053320 |
| 33 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.47122925 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 4.46921338 |
| 35 | regulation of chemokine biosynthetic process (GO:0045073) | 4.46815225 |
| 36 | positive regulation of interleukin-12 production (GO:0032735) | 4.41755380 |
| 37 | regulation of T-helper 1 type immune response (GO:0002825) | 4.41718093 |
| 38 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.41540091 |
| 39 | * natural killer cell activation involved in immune response (GO:0002323) | 4.37187093 |
| 40 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.32869582 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 4.31668501 |
| 42 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.29761674 |
| 43 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.27284055 |
| 44 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 4.23881090 |
| 45 | response to muramyl dipeptide (GO:0032495) | 4.15623271 |
| 46 | * defense response to virus (GO:0051607) | 4.10069772 |
| 47 | eosinophil chemotaxis (GO:0048245) | 4.09287677 |
| 48 | positive regulation of interleukin-17 production (GO:0032740) | 4.08324781 |
| 49 | negative regulation of amino acid transport (GO:0051956) | 3.99562048 |
| 50 | positive regulation of lymphocyte migration (GO:2000403) | 3.99021397 |
| 51 | * regulation of viral genome replication (GO:0045069) | 3.95734127 |
| 52 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.94353858 |
| 53 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.91353516 |
| 54 | positive regulation of interleukin-2 production (GO:0032743) | 3.87118352 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.86517070 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.86142875 |
| 57 | immunoglobulin mediated immune response (GO:0016064) | 3.85734335 |
| 58 | regulation of interleukin-17 production (GO:0032660) | 3.84717846 |
| 59 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.83556911 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.81573234 |
| 61 | * response to exogenous dsRNA (GO:0043330) | 3.80573930 |
| 62 | * negative regulation of viral process (GO:0048525) | 3.79490466 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.78212525 |
| 64 | regulation of vitamin metabolic process (GO:0030656) | 3.77425070 |
| 65 | positive regulation of defense response to virus by host (GO:0002230) | 3.72847376 |
| 66 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.71044014 |
| 67 | positive regulation of interleukin-10 production (GO:0032733) | 3.70536296 |
| 68 | cellular response to nicotine (GO:0071316) | 3.65362794 |
| 69 | T cell migration (GO:0072678) | 3.64481992 |
| 70 | lymphocyte chemotaxis (GO:0048247) | 3.61363846 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61098315 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 3.61098315 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61098315 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 3.61098315 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61098315 |
| 76 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61098315 |
| 77 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.60751814 |
| 78 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.57234173 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 3.57234173 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 3.57228765 |
| 81 | eosinophil migration (GO:0072677) | 3.56888336 |
| 82 | monocyte chemotaxis (GO:0002548) | 3.55785587 |
| 83 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.55738354 |
| 84 | myeloid dendritic cell differentiation (GO:0043011) | 3.55550172 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 3.55331424 |
| 86 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.54948068 |
| 87 | regulation of immunoglobulin secretion (GO:0051023) | 3.54747527 |
| 88 | positive regulation of activated T cell proliferation (GO:0042104) | 3.54078752 |
| 89 | NIK/NF-kappaB signaling (GO:0038061) | 3.53484590 |
| 90 | response to protozoan (GO:0001562) | 3.49448713 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.48831898 |
| 92 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.46880411 |
| 93 | cellular response to interferon-gamma (GO:0071346) | 3.46457728 |
| 94 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.45598891 |
| 95 | * cellular response to exogenous dsRNA (GO:0071360) | 3.43472848 |
| 96 | positive regulation of T cell mediated immunity (GO:0002711) | 3.42503524 |
| 97 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.41778480 |
| 98 | leukocyte aggregation (GO:0070486) | 3.39536277 |
| 99 | superoxide anion generation (GO:0042554) | 3.39182921 |
| 100 | activation of MAPKKK activity (GO:0000185) | 3.39175121 |
| 101 | negative regulation of interleukin-17 production (GO:0032700) | 3.37183313 |
| 102 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.36148073 |
| 103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.35476481 |
| 104 | positive regulation of leukocyte chemotaxis (GO:0002690) | 3.34921363 |
| 105 | regulation of chronic inflammatory response (GO:0002676) | 3.33656783 |
| 106 | cellular response to virus (GO:0098586) | 3.31835360 |
| 107 | positive regulation of type 2 immune response (GO:0002830) | 3.31103205 |
| 108 | granulocyte activation (GO:0036230) | 3.30886993 |
| 109 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.30648217 |
| 110 | cellular response to lipopolysaccharide (GO:0071222) | 3.30530531 |
| 111 | regulation of mononuclear cell migration (GO:0071675) | 3.30487925 |
| 112 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.29611574 |
| 113 | positive regulation of tumor necrosis factor production (GO:0032760) | 3.28868997 |
| 114 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.28716682 |
| 115 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.28239370 |
| 116 | negative regulation of type I interferon production (GO:0032480) | 3.27969398 |
| 117 | negative regulation of growth of symbiont in host (GO:0044130) | 3.26989020 |
| 118 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.26989020 |
| 119 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.26989020 |
| 120 | regulation of growth of symbiont in host (GO:0044126) | 3.26989020 |
| 121 | positive regulation of humoral immune response (GO:0002922) | 3.26701141 |
| 122 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.26180272 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 3.25886796 |
| 124 | * negative regulation of viral genome replication (GO:0045071) | 3.25513881 |
| 125 | regulation of podosome assembly (GO:0071801) | 3.24857747 |
| 126 | defense response to protozoan (GO:0042832) | 3.24464986 |
| 127 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.24373662 |
| 128 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.22527115 |
| 129 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.22165332 |
| 130 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.21633757 |
| 131 | response to interferon-gamma (GO:0034341) | 3.19400442 |
| 132 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.18340626 |
| 133 | positive regulation of transcription factor import into nucleus (GO:0042993) | 3.17952048 |
| 134 | positive regulation of macrophage cytokine production (GO:0060907) | 3.17754733 |
| 135 | cellular response to molecule of bacterial origin (GO:0071219) | 3.17619111 |
| 136 | * response to interferon-beta (GO:0035456) | 3.17352246 |
| 137 | * regulation of type 2 immune response (GO:0002828) | 3.17053289 |
| 138 | regulation of interferon-beta production (GO:0032648) | 3.16111229 |
| 139 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.15408859 |
| 140 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.15235057 |
| 141 | * response to dsRNA (GO:0043331) | 3.13829166 |
| 142 | positive regulation of acute inflammatory response (GO:0002675) | 3.13443879 |
| 143 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.12210984 |
| 144 | regulation of lymphocyte migration (GO:2000401) | 3.10716495 |
| 145 | positive regulation of interferon-beta production (GO:0032728) | 3.10637482 |
| 146 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.10383580 |
| 147 | regulation of defense response to virus by host (GO:0050691) | 3.10256157 |
| 148 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.09501259 |
| 149 | positive regulation of neutrophil migration (GO:1902624) | 3.09501259 |
| 150 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09354826 |
| 151 | lymphocyte migration (GO:0072676) | 3.07490165 |
| 152 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.06723566 |
| 153 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.05285623 |
| 154 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.05226397 |
| 155 | positive regulation of interleukin-6 production (GO:0032755) | 3.04673780 |
| 156 | dendritic cell differentiation (GO:0097028) | 3.04375313 |
| 157 | * negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03844668 |
| 158 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.01701628 |
| 159 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98120031 |
| 160 | B cell mediated immunity (GO:0019724) | 2.96562993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.32586950 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.91151443 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.61178466 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.57337998 |
| 5 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.52486384 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45044622 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19432551 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.09697113 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95486851 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.43437773 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42036833 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28423929 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15988956 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08852221 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08137605 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 11.6277217 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.99298252 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95703817 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.88071661 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.80065197 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.75147402 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64880873 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62746436 |
| 24 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62093265 |
| 25 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58194763 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56579326 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54344120 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52602658 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.43013651 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.42017967 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41639917 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34016294 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33549352 |
| 34 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30733034 |
| 35 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30586314 |
| 36 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26584070 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24886181 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22503262 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21822227 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20248378 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.18886299 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17813342 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.14046167 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.13816695 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13406896 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12825003 |
| 47 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12763869 |
| 48 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10979965 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08419548 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08419548 |
| 51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07424632 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07408558 |
| 53 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07374055 |
| 54 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07374055 |
| 55 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07374055 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07067207 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06657589 |
| 58 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06456024 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03816241 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02743250 |
| 61 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00765629 |
| 62 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00571096 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99522333 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98891957 |
| 65 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96773524 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93722420 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93545098 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92435633 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91993452 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90330093 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88979884 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88464284 |
| 73 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.87512845 |
| 74 | MAF_26560356_Chip-Seq_TH2_Human | 0.87492617 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86496633 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86443088 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86378652 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86207833 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86170978 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84607640 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84453853 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84195569 |
| 83 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82890589 |
| 84 | * MYB_26560356_Chip-Seq_TH2_Human | 0.82099948 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81916472 |
| 86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.81001519 |
| 87 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80988808 |
| 88 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80803736 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80262972 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80123994 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79548831 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78390769 |
| 93 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.77534638 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76358072 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75955021 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75419366 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.75409548 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74306773 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74142003 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74137055 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.73371079 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72906452 |
| 103 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.71684013 |
| 104 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71424728 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.71402930 |
| 106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.71402930 |
| 107 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.70606974 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69131704 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.68232136 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.67656070 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.67297539 |
| 112 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66149509 |
| 113 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66078893 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65444390 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.64685379 |
| 116 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63955871 |
| 117 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.63696489 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.63568830 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62713814 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62616332 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62580910 |
| 122 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.62219773 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.61998852 |
| 124 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61621334 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.61534549 |
| 126 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.59957607 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59886684 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58949630 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.58436183 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58399351 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58341561 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.57939967 |
| 133 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.57602141 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.57363970 |
| 135 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.56999056 |
| 136 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.56647374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.98246802 |
| 2 | * MP0006082_CNS_inflammation | 4.55442978 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.40008651 |
| 4 | MP0003724_increased_susceptibility_to | 4.39336067 |
| 5 | MP0003436_decreased_susceptibility_to | 4.13549501 |
| 6 | MP0003303_peritoneal_inflammation | 3.96279274 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.57069626 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.55845333 |
| 9 | * MP0002419_abnormal_innate_immunity | 3.10222833 |
| 10 | MP0002006_tumorigenesis | 3.02835848 |
| 11 | * MP0005025_abnormal_response_to | 3.01963693 |
| 12 | MP0009764_decreased_sensitivity_to | 2.84489562 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.43406595 |
| 14 | MP0008004_abnormal_stomach_pH | 2.42710685 |
| 15 | MP0005623_abnormal_meninges_morphology | 2.37051371 |
| 16 | * MP0002723_abnormal_immune_serum | 2.32911635 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.30640063 |
| 18 | MP0004510_myositis | 2.27097703 |
| 19 | MP0001800_abnormal_humoral_immune | 2.21866284 |
| 20 | MP0004947_skin_inflammation | 2.21520107 |
| 21 | MP0009278_abnormal_bone_marrow | 2.19504214 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 2.16833959 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.10838922 |
| 24 | MP0005671_abnormal_response_to | 2.09450524 |
| 25 | MP0001853_heart_inflammation | 2.07504895 |
| 26 | MP0005451_abnormal_body_composition | 2.01457936 |
| 27 | MP0005387_immune_system_phenotype | 1.97328616 |
| 28 | MP0001790_abnormal_immune_system | 1.97328616 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.96530476 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.95951932 |
| 31 | MP0003075_altered_response_to | 1.95604925 |
| 32 | * MP0008469_abnormal_protein_level | 1.89082864 |
| 33 | * MP0001819_abnormal_immune_cell | 1.86323791 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.85594662 |
| 35 | * MP0002420_abnormal_adaptive_immunity | 1.81338632 |
| 36 | MP0005166_decreased_susceptibility_to | 1.72852833 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.70861751 |
| 38 | MP0005164_abnormal_response_to | 1.70160654 |
| 39 | MP0006054_spinal_hemorrhage | 1.67374442 |
| 40 | MP0003828_pulmonary_edema | 1.64957037 |
| 41 | MP0000858_altered_metastatic_potential | 1.61335064 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.56362491 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.55767920 |
| 44 | MP0002254_reproductive_system_inflammat | 1.52282800 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.50734671 |
| 46 | MP0000685_abnormal_immune_system | 1.48485998 |
| 47 | MP0002277_abnormal_respiratory_mucosa | 1.46683964 |
| 48 | MP0000343_altered_response_to | 1.38904233 |
| 49 | MP0002405_respiratory_system_inflammati | 1.38773668 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.37120230 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.37120230 |
| 52 | * MP0003690_abnormal_glial_cell | 1.33308152 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.29507936 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.29379577 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 1.24965676 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.24611819 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.21349033 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.15706249 |
| 59 | MP0004883_abnormal_blood_vessel | 1.14627310 |
| 60 | * MP0000716_abnormal_immune_system | 1.12087865 |
| 61 | MP0005535_abnormal_body_temperature | 1.12020323 |
| 62 | MP0009763_increased_sensitivity_to | 1.11890980 |
| 63 | * MP0003448_altered_tumor_morphology | 1.10979146 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.09630628 |
| 65 | MP0000604_amyloidosis | 1.05378843 |
| 66 | MP0009840_abnormal_foam_cell | 1.04515446 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.03741140 |
| 68 | MP0002163_abnormal_gland_morphology | 1.01997098 |
| 69 | MP0001348_abnormal_lacrimal_gland | 1.01260428 |
| 70 | MP0002933_joint_inflammation | 1.00423074 |
| 71 | MP0005310_abnormal_salivary_gland | 0.98886715 |
| 72 | * MP0002398_abnormal_bone_marrow | 0.96976745 |
| 73 | MP0001542_abnormal_bone_strength | 0.95698327 |
| 74 | MP0005390_skeleton_phenotype | 0.93189716 |
| 75 | MP0002736_abnormal_nociception_after | 0.92856265 |
| 76 | MP0003195_calcinosis | 0.91204795 |
| 77 | MP0001968_abnormal_touch/_nociception | 0.88022855 |
| 78 | MP0003763_abnormal_thymus_physiology | 0.85297203 |
| 79 | * MP0002429_abnormal_blood_cell | 0.84551147 |
| 80 | MP0000249_abnormal_blood_vessel | 0.84236583 |
| 81 | MP0003045_fibrosis | 0.82599738 |
| 82 | MP0003950_abnormal_plasma_membrane | 0.81280913 |
| 83 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78222070 |
| 84 | MP0001501_abnormal_sleep_pattern | 0.77649656 |
| 85 | MP0001873_stomach_inflammation | 0.75574603 |
| 86 | * MP0000920_abnormal_myelination | 0.75477091 |
| 87 | MP0005647_abnormal_sex_gland | 0.72414007 |
| 88 | MP0002722_abnormal_immune_system | 0.70165344 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.70141067 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.70041174 |
| 91 | * MP0000689_abnormal_spleen_morphology | 0.68389718 |
| 92 | MP0008260_abnormal_autophagy | 0.67255111 |
| 93 | MP0003186_abnormal_redox_activity | 0.66367676 |
| 94 | MP0005023_abnormal_wound_healing | 0.65630845 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.64374121 |
| 96 | MP0005266_abnormal_metabolism | 0.63659318 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.63571009 |
| 98 | MP0002693_abnormal_pancreas_physiology | 0.62909531 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.62342678 |
| 100 | MP0001851_eye_inflammation | 0.62158940 |
| 101 | MP0008874_decreased_physiological_sensi | 0.59576829 |
| 102 | MP0004484_altered_response_of | 0.58779683 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.57249787 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.56619652 |
| 105 | MP0003252_abnormal_bile_duct | 0.55947275 |
| 106 | MP0010307_abnormal_tumor_latency | 0.55377534 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.55027921 |
| 108 | MP0002168_other_aberrant_phenotype | 0.54862971 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.54748917 |
| 110 | MP0001663_abnormal_digestive_system | 0.53435613 |
| 111 | MP0004130_abnormal_muscle_cell | 0.51517777 |
| 112 | MP0001346_abnormal_lacrimal_gland | 0.51411356 |
| 113 | * MP0003795_abnormal_bone_structure | 0.49560633 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.48471992 |
| 115 | MP0009115_abnormal_fat_cell | 0.47776398 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.46727688 |
| 117 | MP0001958_emphysema | 0.43806801 |
| 118 | MP0003091_abnormal_cell_migration | 0.43572217 |
| 119 | MP0003646_muscle_fatigue | 0.42800997 |
| 120 | MP0005165_increased_susceptibility_to | 0.42363257 |
| 121 | MP0008873_increased_physiological_sensi | 0.42197918 |
| 122 | MP0000609_abnormal_liver_physiology | 0.41027531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.80237889 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.33372182 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.27120484 |
| 4 | Eczematoid dermatitis (HP:0000976) | 6.08653180 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 6.06159044 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.69318220 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.67114964 |
| 8 | Stomatitis (HP:0010280) | 5.65937681 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 5.34552424 |
| 10 | Optic neuritis (HP:0100653) | 5.34552424 |
| 11 | Orchitis (HP:0100796) | 5.17118795 |
| 12 | Loss of speech (HP:0002371) | 4.92089432 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.74501815 |
| 14 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.66957309 |
| 15 | Myositis (HP:0100614) | 4.63778620 |
| 16 | Basal ganglia calcification (HP:0002135) | 4.46861948 |
| 17 | Interstitial pulmonary disease (HP:0006530) | 4.28886562 |
| 18 | Recurrent skin infections (HP:0001581) | 3.86074664 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.84109145 |
| 20 | Prolonged neonatal jaundice (HP:0006579) | 3.78577999 |
| 21 | Hemorrhage of the eye (HP:0011885) | 3.76648136 |
| 22 | Vasculitis (HP:0002633) | 3.70909512 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.70224735 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.67966080 |
| 25 | Nuclear cataract (HP:0100018) | 3.64785532 |
| 26 | Axonal loss (HP:0003447) | 3.55928590 |
| 27 | Mutism (HP:0002300) | 3.42085508 |
| 28 | Gingivitis (HP:0000230) | 3.38489577 |
| 29 | Petechiae (HP:0000967) | 3.35578287 |
| 30 | Prostate neoplasm (HP:0100787) | 3.24231495 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.22943052 |
| 32 | Purpura (HP:0000979) | 3.21095194 |
| 33 | Fused cervical vertebrae (HP:0002949) | 3.16801723 |
| 34 | Porencephaly (HP:0002132) | 3.15308472 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.12594906 |
| 36 | Nausea (HP:0002018) | 3.12184445 |
| 37 | Poor head control (HP:0002421) | 3.11013386 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 3.06994092 |
| 39 | Hepatosplenomegaly (HP:0001433) | 3.03140741 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02957985 |
| 41 | Obstructive lung disease (HP:0006536) | 3.02957985 |
| 42 | Recurrent fungal infections (HP:0002841) | 3.01117269 |
| 43 | Apathy (HP:0000741) | 2.99805992 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.99535486 |
| 45 | Abnormality of the pericardium (HP:0001697) | 2.97636819 |
| 46 | Spastic tetraparesis (HP:0001285) | 2.90249148 |
| 47 | Agnosia (HP:0010524) | 2.89070627 |
| 48 | Disinhibition (HP:0000734) | 2.87069062 |
| 49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86428285 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86428285 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86428285 |
| 52 | Diminished motivation (HP:0000745) | 2.82621791 |
| 53 | Nephritis (HP:0000123) | 2.81807812 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.81673915 |
| 55 | Hematochezia (HP:0002573) | 2.80790396 |
| 56 | Pigmentary retinal degeneration (HP:0001146) | 2.80523129 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 2.78553257 |
| 58 | Arterial thrombosis (HP:0004420) | 2.77775681 |
| 59 | Parakeratosis (HP:0001036) | 2.70153731 |
| 60 | Pustule (HP:0200039) | 2.69617431 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68234031 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.68234031 |
| 63 | Increased serum ferritin (HP:0003281) | 2.66313739 |
| 64 | Myocardial infarction (HP:0001658) | 2.65593826 |
| 65 | Joint swelling (HP:0001386) | 2.62633194 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.61330288 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.61330288 |
| 68 | Recurrent viral infections (HP:0004429) | 2.60931992 |
| 69 | Periodontitis (HP:0000704) | 2.60278481 |
| 70 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.56964542 |
| 71 | Polyneuropathy (HP:0001271) | 2.56468626 |
| 72 | Cellulitis (HP:0100658) | 2.49317272 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.49204875 |
| 74 | Choroideremia (HP:0001139) | 2.48730590 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.48158372 |
| 76 | Joint hemorrhage (HP:0005261) | 2.47735726 |
| 77 | Lower limb hyperreflexia (HP:0002395) | 2.47623923 |
| 78 | Hemoptysis (HP:0002105) | 2.43496163 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40736450 |
| 80 | Inappropriate behavior (HP:0000719) | 2.39923409 |
| 81 | Encephalitis (HP:0002383) | 2.37890255 |
| 82 | T lymphocytopenia (HP:0005403) | 2.37510665 |
| 83 | Xerostomia (HP:0000217) | 2.37258648 |
| 84 | Cleft eyelid (HP:0000625) | 2.36330631 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.33506139 |
| 86 | Acrocyanosis (HP:0001063) | 2.33303258 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.31356242 |
| 88 | Glomerulonephritis (HP:0000099) | 2.30850833 |
| 89 | Meningitis (HP:0001287) | 2.27536620 |
| 90 | Anorexia (HP:0002039) | 2.25742772 |
| 91 | Vertigo (HP:0002321) | 2.25020594 |
| 92 | Abnormality of the endocardium (HP:0004306) | 2.24886899 |
| 93 | Abnormality of B cell number (HP:0010975) | 2.23436026 |
| 94 | Bone pain (HP:0002653) | 2.21516280 |
| 95 | Gingival bleeding (HP:0000225) | 2.20697988 |
| 96 | Memory impairment (HP:0002354) | 2.19774339 |
| 97 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.19047172 |
| 98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.17951170 |
| 99 | Amyloidosis (HP:0011034) | 2.16802630 |
| 100 | Thick nail (HP:0001805) | 2.15224763 |
| 101 | Arthralgia (HP:0002829) | 2.14026058 |
| 102 | Stenosis of the external auditory canal (HP:0000402) | 2.12039285 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 2.11778744 |
| 104 | Nasal polyposis (HP:0100582) | 2.10209257 |
| 105 | Increased IgM level (HP:0003496) | 2.10150100 |
| 106 | Leukocytosis (HP:0001974) | 2.09333912 |
| 107 | Metaphyseal irregularity (HP:0003025) | 2.07966485 |
| 108 | B lymphocytopenia (HP:0010976) | 2.07882022 |
| 109 | Progressive visual loss (HP:0000529) | 2.07189970 |
| 110 | Pulmonary artery stenosis (HP:0004415) | 2.06381427 |
| 111 | Pathologic fracture (HP:0002756) | 2.05432616 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.04944161 |
| 113 | Recurrent pneumonia (HP:0006532) | 2.04681104 |
| 114 | Glomerulopathy (HP:0100820) | 2.03713891 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 2.02495127 |
| 116 | Personality changes (HP:0000751) | 2.00789381 |
| 117 | Thoracolumbar scoliosis (HP:0002944) | 2.00006874 |
| 118 | Abnormality of the basal ganglia (HP:0002134) | 1.99259848 |
| 119 | Acne (HP:0001061) | 1.99077251 |
| 120 | Urticaria (HP:0001025) | 1.97524783 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.97431123 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.96423244 |
| 123 | Neurofibrillary tangles (HP:0002185) | 1.93473290 |
| 124 | Pulmonary embolism (HP:0002204) | 1.91933865 |
| 125 | Osteomyelitis (HP:0002754) | 1.89690522 |
| 126 | Gangrene (HP:0100758) | 1.89685820 |
| 127 | Plagiocephaly (HP:0001357) | 1.88770532 |
| 128 | Upper motor neuron abnormality (HP:0002127) | 1.88400357 |
| 129 | Cheilitis (HP:0100825) | 1.86800862 |
| 130 | Abnormality of complement system (HP:0005339) | 1.85300692 |
| 131 | Micronodular cirrhosis (HP:0001413) | 1.83289678 |
| 132 | Abnormality of the nasal septum (HP:0000419) | 1.81310782 |
| 133 | Hemiparesis (HP:0001269) | 1.80782809 |
| 134 | Chronic otitis media (HP:0000389) | 1.76795295 |
| 135 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.75287491 |
| 136 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75287491 |
| 137 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75287491 |
| 138 | Premature loss of primary teeth (HP:0006323) | 1.75271399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.96899419 |
| 2 | IRAK3 | 4.57524417 |
| 3 | BLK | 4.16594198 |
| 4 | TBK1 | 4.07444908 |
| 5 | RIPK4 | 3.87443908 |
| 6 | PBK | 3.71792702 |
| 7 | TXK | 3.49529662 |
| 8 | RIPK1 | 3.47305246 |
| 9 | ADRBK2 | 2.84829677 |
| 10 | FGFR4 | 2.83080856 |
| 11 | FGR | 2.80976020 |
| 12 | PIM2 | 2.51467547 |
| 13 | MAP3K13 | 2.49736752 |
| 14 | IKBKB | 2.49365889 |
| 15 | IRAK4 | 2.45591038 |
| 16 | DDR2 | 2.36790336 |
| 17 | PRPF4B | 2.34714951 |
| 18 | IKBKE | 2.16145979 |
| 19 | MAP4K1 | 2.15352789 |
| 20 | JAK3 | 1.91709382 |
| 21 | BMX | 1.83355321 |
| 22 | CSK | 1.81410554 |
| 23 | TAOK1 | 1.78118151 |
| 24 | GRK7 | 1.64526998 |
| 25 | MAP3K11 | 1.63697727 |
| 26 | CHUK | 1.57068698 |
| 27 | FGFR3 | 1.51018245 |
| 28 | MAP3K3 | 1.48493692 |
| 29 | BMPR2 | 1.48393456 |
| 30 | TYK2 | 1.44258652 |
| 31 | JAK1 | 1.40792604 |
| 32 | PIM1 | 1.40343549 |
| 33 | BCKDK | 1.32551541 |
| 34 | CSF1R | 1.30925807 |
| 35 | IRAK2 | 1.29805579 |
| 36 | ERBB4 | 1.27285454 |
| 37 | ARAF | 1.23218054 |
| 38 | EIF2AK2 | 1.22705512 |
| 39 | LYN | 1.22542770 |
| 40 | ABL2 | 1.20708694 |
| 41 | MAP3K5 | 1.17511097 |
| 42 | HCK | 1.17460991 |
| 43 | SYK | 1.16010306 |
| 44 | BTK | 1.13785607 |
| 45 | TAOK3 | 1.05974913 |
| 46 | CDC42BPA | 1.01644527 |
| 47 | SIK3 | 0.99573200 |
| 48 | MAP2K3 | 0.98428955 |
| 49 | LATS2 | 0.94634224 |
| 50 | TESK1 | 0.93781987 |
| 51 | ERN1 | 0.93603503 |
| 52 | TEC | 0.92896669 |
| 53 | IRAK1 | 0.91948496 |
| 54 | KIT | 0.89226001 |
| 55 | ZAP70 | 0.88781215 |
| 56 | ERBB3 | 0.88383702 |
| 57 | JAK2 | 0.87088638 |
| 58 | LCK | 0.83821446 |
| 59 | TGFBR2 | 0.82555072 |
| 60 | NME2 | 0.81721834 |
| 61 | PRKCD | 0.81382143 |
| 62 | CLK1 | 0.80698364 |
| 63 | MATK | 0.80010138 |
| 64 | MAPK11 | 0.79829082 |
| 65 | MST4 | 0.76633540 |
| 66 | EPHB2 | 0.76496391 |
| 67 | TRPM7 | 0.75808173 |
| 68 | ABL1 | 0.75608118 |
| 69 | NEK9 | 0.75332052 |
| 70 | MAP3K12 | 0.73278566 |
| 71 | STK10 | 0.72419050 |
| 72 | TYRO3 | 0.67468148 |
| 73 | TESK2 | 0.67000516 |
| 74 | MST1R | 0.63432611 |
| 75 | DAPK3 | 0.62931815 |
| 76 | HIPK2 | 0.60521710 |
| 77 | FES | 0.59852246 |
| 78 | DYRK3 | 0.58078865 |
| 79 | YES1 | 0.56188178 |
| 80 | ACVR1B | 0.55498550 |
| 81 | EGFR | 0.53941281 |
| 82 | PRKCQ | 0.52487687 |
| 83 | TRIB3 | 0.50064216 |
| 84 | FYN | 0.49372983 |
| 85 | ADRBK1 | 0.49156893 |
| 86 | ITK | 0.43975833 |
| 87 | EPHA3 | 0.43752553 |
| 88 | INSR | 0.42541742 |
| 89 | LRRK2 | 0.41840080 |
| 90 | STK3 | 0.41191232 |
| 91 | PTK6 | 0.38757526 |
| 92 | PLK2 | 0.37936767 |
| 93 | PRKCH | 0.37930762 |
| 94 | IGF1R | 0.37921252 |
| 95 | MUSK | 0.36731834 |
| 96 | PRKCG | 0.35790989 |
| 97 | KSR2 | 0.34197591 |
| 98 | STK4 | 0.33461422 |
| 99 | PRKCE | 0.32549794 |
| 100 | PDGFRA | 0.30644504 |
| 101 | MAP2K6 | 0.29990860 |
| 102 | TNK2 | 0.28045228 |
| 103 | STK24 | 0.27451240 |
| 104 | MAPK7 | 0.27366411 |
| 105 | MOS | 0.27121194 |
| 106 | RPS6KA5 | 0.26199375 |
| 107 | SIK1 | 0.25309907 |
| 108 | CAMK2G | 0.21518090 |
| 109 | MARK3 | 0.20682265 |
| 110 | CDK4 | 0.20327782 |
| 111 | SRC | 0.19930750 |
| 112 | FGFR1 | 0.19092493 |
| 113 | PDK1 | 0.18991194 |
| 114 | ICK | 0.18739853 |
| 115 | MAP3K1 | 0.16598588 |
| 116 | MAP3K8 | 0.16436869 |
| 117 | CDK6 | 0.16156633 |
| 118 | PKN1 | 0.16131408 |
| 119 | PRKACG | 0.15361726 |
| 120 | PRKCA | 0.15157350 |
| 121 | DAPK2 | 0.14527003 |
| 122 | TTN | 0.14337449 |
| 123 | MAPKAPK2 | 0.13342303 |
| 124 | SGK1 | 0.13252747 |
| 125 | SIK2 | 0.12558657 |
| 126 | CDK9 | 0.11838455 |
| 127 | TAOK2 | 0.11534791 |
| 128 | MAPK3 | 0.11355425 |
| 129 | BMPR1B | 0.11228570 |
| 130 | PIK3CG | 0.11005658 |
| 131 | PRKG2 | 0.10492259 |
| 132 | MAPK4 | 0.09804062 |
| 133 | PRKCB | 0.09791596 |
| 134 | CDK14 | 0.09559823 |
| 135 | EPHB1 | 0.09295035 |
| 136 | PAK4 | 0.09232821 |
| 137 | BRAF | 0.08531430 |
| 138 | CAMK2A | 0.08194316 |
| 139 | RPS6KA1 | 0.08138002 |
| 140 | CDK15 | 0.06194386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 6.37763479 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.38809542 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.39131191 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.27738583 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 3.27112062 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.20561997 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.99649549 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.99424921 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78861957 |
| 10 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.76442059 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.71696894 |
| 12 | Salmonella infection_Homo sapiens_hsa05132 | 2.62258320 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.46208159 |
| 14 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.45953242 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.36884695 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.04985360 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.04869021 |
| 18 | * Tuberculosis_Homo sapiens_hsa05152 | 2.04230253 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.03167333 |
| 20 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.91254465 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.87274030 |
| 22 | Prion diseases_Homo sapiens_hsa05020 | 1.85657931 |
| 23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.74507813 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69730716 |
| 25 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65957037 |
| 26 | * Measles_Homo sapiens_hsa05162 | 1.59550377 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51843093 |
| 28 | * Influenza A_Homo sapiens_hsa05164 | 1.35359290 |
| 29 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28984899 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.24967808 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22148184 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15947308 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.10777928 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08633617 |
| 35 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.94853749 |
| 36 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94420985 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85475701 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83304455 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82983245 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82756808 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.81327147 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 0.69383086 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 0.67617749 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 0.65417134 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63382422 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62934478 |
| 47 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62421369 |
| 48 | * Hepatitis B_Homo sapiens_hsa05161 | 0.60262279 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59247432 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.58691020 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56657744 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51659890 |
| 53 | * Hepatitis C_Homo sapiens_hsa05160 | 0.50746820 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46287065 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44184479 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44042751 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42721085 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40094487 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39098644 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33953915 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32753771 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31151481 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29629220 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28679500 |
| 65 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.25778090 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24750119 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21819542 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.20694217 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20302625 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20002668 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19856241 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19829757 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19442504 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.18972838 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.18138344 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.17105667 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16307024 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14710687 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14669443 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.13326859 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12487373 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.12146587 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11885354 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11086140 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.09996783 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.09409403 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.09310088 |
| 88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08553897 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07650961 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.07508585 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.07076867 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06929581 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.06402670 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.06397226 |
| 95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.06316181 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.04681341 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.04493353 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.04095636 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02744809 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02229025 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02098339 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.01939857 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.01800882 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.01719241 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01547447 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.01446464 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.01000923 |
| 108 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.00570276 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00439989 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0574356 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | -0.0410827 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0333340 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | -0.0282333 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | -0.0224663 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | -0.0210407 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | -0.0176096 |
| 117 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0117815 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | -0.0037100 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0011307 |

